201 related articles for article (PubMed ID: 27182202)
1. Lyn, a tyrosine kinase closely linked to the differentiation status of primary acute myeloid leukemia blasts, associates with negative regulation of all-trans retinoic acid (ATRA) and dihydroxyvitamin D3 (VD3)-induced HL-60 cells differentiation.
Iriyama N; Yuan B; Hatta Y; Takagi N; Takei M
Cancer Cell Int; 2016; 16():37. PubMed ID: 27182202
[TBL] [Abstract][Full Text] [Related]
2. Roscovitine enhances All-trans retinoic acid (ATRA)-induced leukemia cell differentiation: Novel effects on signaling molecules for a putative Cdk2 inhibitor.
Rashid A; Duan X; Gao F; Yang M; Yen A
Cell Signal; 2020 Jul; 71():109555. PubMed ID: 32032659
[TBL] [Abstract][Full Text] [Related]
3. Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells.
Congleton J; MacDonald R; Yen A
Leukemia; 2012 Jun; 26(6):1180-8. PubMed ID: 22182854
[TBL] [Abstract][Full Text] [Related]
4. Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3.
Lu H; Weng XQ; Sheng Y; Wu J; Xi HM; Cai X
BMC Cancer; 2022 Jul; 22(1):749. PubMed ID: 35810308
[TBL] [Abstract][Full Text] [Related]
5. Dasatinib synergizes with ATRA to trigger granulocytic differentiation in ATRA resistant acute promyelocytic leukemia cell lines via Lyn inhibition-mediated activation of RAF-1/MEK/ERK.
Ding M; Weng XQ; Sheng Y; Wu J; Liang C; Cai X
Food Chem Toxicol; 2018 Sep; 119():464-478. PubMed ID: 29097117
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity.
Congleton J; Shen M; MacDonald R; Malavasi F; Yen A
Cell Signal; 2014 Jul; 26(7):1589-97. PubMed ID: 24686085
[TBL] [Abstract][Full Text] [Related]
7. l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)
Song JH; Park E; Kim MS; Cho KM; Park SH; Lee A; Song J; Kim HJ; Koh JT; Kim TS
Int J Cancer; 2017 May; 140(10):2364-2374. PubMed ID: 28224619
[TBL] [Abstract][Full Text] [Related]
8. Modulation of CD157 expression in multi-lineage myeloid differentiation of promyelocytic cell lines.
Hussain AM; Lee HC; Chang CF
Eur J Cell Biol; 2000 Oct; 79(10):697-706. PubMed ID: 11089918
[TBL] [Abstract][Full Text] [Related]
9. EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells.
Lainey E; Wolfromm A; Sukkurwala AQ; Micol JB; Fenaux P; Galluzzi L; Kepp O; Kroemer G
Cell Cycle; 2013 Sep; 12(18):2978-91. PubMed ID: 23974111
[TBL] [Abstract][Full Text] [Related]
10. Ethacrynic acid and 1 alpha,25-dihydroxyvitamin D3 cooperatively inhibit proliferation and induce differentiation of human myeloid leukemia cells.
Makishima M; Honma Y
Leuk Res; 1996 Sep; 20(9):781-9. PubMed ID: 8947589
[TBL] [Abstract][Full Text] [Related]
11. The Bromodomain Inhibitor JQ1 Enhances the Responses to All-
Kang C; Kim CY; Kim HS; Park SP; Chung HM
Int J Stem Cells; 2018 May; 11(1):131-140. PubMed ID: 29699387
[TBL] [Abstract][Full Text] [Related]
12. Enzastaurin enhances ATRA-induced differentiation of acute myeloid leukemia cells.
Li ZY; Liang C; Ding M; Weng XQ; Sheng Y; Wu J; Lu H; Cai X
Am J Transl Res; 2020; 12(12):7836-7854. PubMed ID: 33437364
[TBL] [Abstract][Full Text] [Related]
13. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
14. A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia.
Redner RL; Beumer JH; Kropf P; Agha M; Boyiadzis M; Dorritie K; Farah R; Hou JZ; Im A; Lim SH; Raptis A; Sehgal A; Christner SM; Normolle D; Johnson DE
Leuk Lymphoma; 2018 Nov; 59(11):2595-2601. PubMed ID: 29616864
[TBL] [Abstract][Full Text] [Related]
15. Evidence of off-target effects of bosutinib that promote retinoic acid-induced differentiation of non-APL AML cells.
Kazim N; Yen A
Cell Cycle; 2021 Dec; 20(24):2638-2651. PubMed ID: 34836491
[TBL] [Abstract][Full Text] [Related]
16. Vibsanin A sensitizes human acute myeloid leukemia cells to tyrosine kinase inhibitor-induced myeloid differentiation via activation of PKC and upregulation of Lyn.
Shen X; Xing S; Zhang L; Wang F; Ou H; Shan Y; Xiao H; Xiong G; Wang X; Zhao Q; Cong Y; Yu Z
Biochem Biophys Res Commun; 2018 Jul; 502(1):110-115. PubMed ID: 29787755
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells.
Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
Clin Cancer Res; 2016 Mar; 22(5):1211-21. PubMed ID: 26459180
[TBL] [Abstract][Full Text] [Related]
18. Notopterol-induced apoptosis and differentiation in human acute myeloid leukemia HL-60 cells.
Huang Q; Wang L; Ran Q; Wang J; Wang C; He H; Li L; Qi H
Drug Des Devel Ther; 2019; 13():1927-1940. PubMed ID: 31239643
[No Abstract] [Full Text] [Related]
19. Trametinib enhances ATRA-induced differentiation in AML cells.
Lu H; Li ZY; Ding M; Liang C; Weng XQ; Sheng Y; Wu J; Cai X
Leuk Lymphoma; 2021 Dec; 62(14):3361-3372. PubMed ID: 34355652
[TBL] [Abstract][Full Text] [Related]
20. A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3.
Kanatani Y; Makishima M; Ishikawa I; Ogasawara Y; Kawahara N; Motoyoshi K; Nagata N; Honma Y
Exp Hematol; 1998 Mar; 26(3):198-206. PubMed ID: 9502615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
